Company Number: 14225856

Analysis Date: 2025-07-19 13:06 UTC

Financial Health Assessment of GLENNINA LTD (Year Ending 31 July 2024)

---

1. Financial Health Score: C+

Explanation:
GLENNINA LTD demonstrates basic financial stability with positive net current assets and shareholders’ funds. However, the company's financial position shows signs of fragility and limited operational scale given the micro-entity status, low asset base, and absence of employees. The increase in net current assets from the prior year is a positive symptom, but the overall size and activity suggest cautious optimism rather than robust health.

---

2. Key Vital Signs (Critical Metrics & Interpretation):

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Current Assets	167,200	424,592	Significant reduction year-on-year; possibly reduced cash or receivables.
Current Liabilities	140,371	423,795	Large drop in short-term debts, a positive sign of improved liquidity.
Net Current Assets	26,829	797	Healthy increase indicating better short-term financial cushion.
Shareholders’ Funds	26,829	797	Increased equity base, showing retained profits or capital injection.
Number of Employees	0	0	No payroll expenses; company likely non-operational or service-based.

• Liquidity (Net Current Assets): The positive net current assets (£26.8k) indicate the company has a “healthy cash flow” buffer to cover short-term obligations, a vital sign of financial wellbeing.
• Capital Structure: Shareholders’ funds increased significantly, demonstrating a stronger equity base, which reduces insolvency risk.
• Asset Base: The dramatic decrease in current assets, particularly cash (from £424k to £167k), suggests usage of funds—either investments, expenses, or distributions. Monitoring this trend is critical to ensure liquidity is maintained.
• Employee Count: Zero employees indicate limited operational activity and possibly reliance on outsourcing or directors’ involvement without payroll expenses.

---

3. Diagnosis (What the Financial Data Reveals):

GLENNINA LTD is in a nascent or early operational stage, typical for a micro-entity formed recently (incorporated mid-2022). The company shows symptoms of cautious financial health: it maintains positive working capital and improved shareholders’ funds, which are signs of financial strength and solvency.

However, the sharp drop in current assets and a lack of employees suggest limited business activity or a strategic decision to conserve resources. The company is not showing signs of distress such as negative net assets or overdue filings, but the small scale and volatile asset base mean it is vulnerable to shocks.

The absence of audit requirements and reliance on micro-entity provisions reflect a simple financial structure, but this simplicity also means less detailed financial transparency for external stakeholders.

---

4. Recommendations (Specific Actions to Improve Financial Wellness):

• Cash Flow Management: Carefully monitor cash balances and current liabilities to avoid liquidity crunches. Consider maintaining a minimum cash reserve to handle unexpected expenses.
• Operational Scale: Evaluate the business model to increase operational activity or revenue streams, potentially hiring staff or outsourcing strategically to drive growth.
• Financial Planning: Develop a short- to medium-term financial plan with forecasts to anticipate funding needs or investment opportunities. This helps avoid “symptoms of distress” like sudden cash depletion.
• Stakeholder Communication: Maintain clear reporting and transparency with shareholders and creditors to build trust and ease access to external financing if needed.
• Cost Control: Continue to keep overheads low but ensure investment in critical growth areas—such as marketing or technology—to support business expansion.
• Compliance Vigilance: Keep up with filing deadlines and statutory obligations to avoid penalties and reputational damage.

---

Medical Analogy Summary:

GLENNINA LTD’s financial health is akin to a patient with a stable but modest heartbeat—there is no immediate crisis, but the body is small and still developing. The company benefits from a “healthy cash flow pulse” but must nurture its financial “immune system” by carefully managing liquidity and scaling operations to avoid future “symptoms of distress.”

---